Cellectis (CLLS) Common Equity: 2014-2022
Historic Common Equity for Cellectis (CLLS) over the last 9 years, with Dec 2022 value amounting to $7.2 million.
- Cellectis' Common Equity was N/A to $76.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $76.1 million, marking a year-over-year change of. This contributed to the annual value of $7.2 million for FY2022, which is 48.82% down from last year.
- As of FY2022, Cellectis' Common Equity stood at $7.2 million, which was down 48.82% from $14.1 million recorded in FY2021.
- In the past 5 years, Cellectis' Common Equity ranged from a high of $450.3 million in FY2018 and a low of $7.2 million during FY2022.
- For the 3-year period, Cellectis' Common Equity averaged around $110.1 million, with its median value being $14.1 million (2021).
- In the last 5 years, Cellectis' Common Equity skyrocketed by 58.55% in 2018 and then crashed by 95.42% in 2021.
- Over the past 5 years, Cellectis' Common Equity (Yearly) stood at $450.3 million in 2018, then plummeted by 30.01% to $315.1 million in 2019, then declined by 1.99% to $308.8 million in 2020, then crashed by 95.42% to $14.1 million in 2021, then crashed by 48.82% to $7.2 million in 2022.